Lack of awareness continues to hinder use of group benefit programs.

The company improved its net income on the Canadian front.

Management underlines new business value growth.

Insurers are already receiving numerous claims for a new appetite-suppressing drug.

Denis Ricard highlights recent acquisitions in high-growth sectors.

Company reports strong performance driven by U.S. operations.

Volatility is raging, but fears of an imminent recession are fading.